SIM Acquisition Corp. I (SIMA) 股票分析
金融服务SIM Acquisition Corp. I
$10.77
+$0.01 (+0.09%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
SIM Acquisition Corp. I operates primarily within the financial services sector, specifically classified under the industry of shell companies, with a distinct strategic focus on executing business combinations within the healthcare sector. Incorporated in 2024, the entity does not maintain significant ongoing operations and is dedicated to effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more healthcare businesses. The company's market capitalization stands at $328.75M, while reported annual revenue is not applicable (N/A), and the number of employees is listed as not applicable (N/A). The substantial market cap relative to the lack of significant current operations and N/A revenue figures indicates that the company's valuation is driven entirely by its potential future value upon completing a business combination, rather than current cash flow generation or established revenue streams typical of operating companies.
财务健康
The financial statements for SIM Acquisition Corp. I reveal a net income of $8.79M over the trailing twelve months (TTM), while reported revenue is N/A and EBITDA is N/A, suggesting a financial structure where income is generated through non-operating activities or specific transactional fees rather than core sales. The gap between the reported net income of $8.79M and the absence of revenue data indicates that the company's profitability currently stems from sources other than traditional sales, likely related to its shell status and capital structure. Free cash flow is recorded at -$434,468, which signifies a net cash outflow that reflects the typical cash burn associated with a pre-business combination shell company awaiting a merger transaction. Regarding margins, the gross margin, operating margin, and profit margin are all 0.0%, which confirms the absence of significant operating revenue and indicates that the company has not yet established a profitable operating model. The balance sheet shows cash holdings of $65,427 against zero debt, resulting in a debt-to-equity ratio that is not applicable (N/A), though the lack of debt suggests a conservative leverage position typical for special purpose acquisition companies (SPACs). However, the current ratio stands at 0.89, which indicates that current liabilities slightly exceed current assets, presenting a potential short-term liquidity constraint before a merger is finalized. Return on Equity is not applicable (N/A) due to the lack of meaningful equity operations, while Return on Assets is -0.3%, revealing that the company is currently utilizing its assets to generate a slight negative return, consistent with a dormant shell entity awaiting a target acquisition.
估值评估
The trailing twelve-month (TTM) price-to-earnings (P/E) ratio is 36.97, whereas the forward P/E is not applicable (N/A), implying that analysts cannot project future earnings based on current financial performance due to the company's lack of significant operations. The price-to-book ratio is -30.20, a negative figure that indicates the market capitalization is valued significantly below the company's net asset value, reflecting the high risk premium associated with shell companies that may fail to complete a merger. Since revenue is N/A, the price-to-sales ratio is not applicable, and similarly, the EV/EBITDA is not applicable, meaning traditional multiple-based valuation metrics are ineffective for assessing the company's current operational value. The stock has traded with a 52-week high of $10.78 and a 52-week low of $10.20, and given the market cap of $328.75M and the specific valuation metrics provided, the current trading price sits within a very narrow range indicative of low liquidity and limited price discovery. The beta is not applicable (N/A), which suggests that the stock's volatility cannot be reliably compared to the broader market index due to its unique status as a special purpose acquisition company with no established historical correlation data.
Growth & Income
Revenue growth year-over-year is not applicable (N/A) because the company has not generated significant revenue, while earnings growth year-over-year is -13.2%, indicating a contraction in net income relative to the previous reporting period. Since earnings have declined by 13.2% while revenue remains non-existent, the earnings trajectory is driven by changes in non-operating income or expenses rather than business expansion. The company does not pay dividends, evidenced by a dividend yield of not applicable (N/A) and a payout ratio of 0.0%, confirming that all available earnings are retained within the company to fund the search for a merger target rather than being distributed to shareholders. Consequently, the overall growth and income profile of SIM Acquisition Corp. I is characterized by a lack of current income generation and negative earnings growth, with the entire strategic focus directed toward capitalizing on future business combinations rather than delivering immediate financial returns or dividend income.
同行比较
SIM Acquisition Corp. I (SIMA) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| SIM Acquisition Corp. I | SIMA | $88.52M | 37.1 |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。SIM Acquisition Corp. I的市盈率为37.1。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于SIM Acquisition Corp. I
SIM Acquisition Corp. I does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses in the healthcare sectors. SIM Acquisition Corp. I was incorporated in 2024 and is based in New York, New York.
公司简介以英文显示。
访问官网 →